Upgrade to SI Premium - Free Trial

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $100 at Citi Following 4Q

February 23, 2018 7:11 AM
Citi raised its price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $100.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles